Scandion Oncology A/S — Credit Rating and Financial Key Figures

Scandion Oncology A/S (CVR number: 38613391K) is a company from KØBENHAVN. The company recorded a gross profit of 0 kDKK in 2024. The operating profit was -41.1 mDKK, while net earnings were -36.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was -152.8 %, which can be considered poor and Return on Equity (ROE) was -186.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 45.2 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Scandion Oncology A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.